We invite you to the webinar “Shorter All-Oral TB Treatment Regimens and Side Effects”
Date: November 28, 2025
Time: 14:00–15:30 (CET)
Languages: English / Russian (simultaneous interpretation)
Registration: https://us06web.zoom.us/meeting/register/xl-uBQoDRSOTIY2zPKVOZQ
The webinar aims to strengthen the capacity of healthcare professionals and community representatives affected by tuberculosis in implementing and promoting short, fully oral regimens for the treatment of drug-resistant TB (DR-TB).
Participants will learn about key clinical principles, management of side effects, and patient-centered approaches. The goal is to promote evidence-based and humanized practices that enhance adherence and improve treatment outcomes.
Who may be interested in
this webinar:
• Healthcare professionals
• Civil society representatives
• Activists and members of communities affected by TB
• Partners and stakeholders from Eastern Europe and Central Asia (EECA) and other regions
PROGRAM:
• Welcome remarks from national representatives – Dr. Valentina Vilc (NTP, Moldova) and Dr. Oktam
Bobokhodjaiev (Tajikistan)
• Clinical aspects of short, fully oral TB treatment regimens and management
of side effects – Jennifer Furin, MD, PhD, an infectious diseases clinician and
a medical anthropologist, the director of Clinical Capacity Building for the
Sentinel Project on Pediatric DR-TB
• Personal stories from people who
have completed short treatment regimens – representatives from Moldova and
Tajikistan
• Q&A session – all participants
Moderators: Lesia Tonkonoh (TBEC), Oxana Ruscineanu (SMIT, Moldova), Shodmon Khushvakhtov (KNCV, Tajikistan)
Join us to learn about the latest clinical approaches, exchange practical experiences, and support the implementation of effective and people-centered DR-TB treatment regimens!
Register today: https://us06web.zoom.us/meeting/register/xl-uBQoDRSOTIY2zPKVOZQ
The event is part of the "The ABC for TB Activist" webinar series and is organized by SMIT (Moldova), KNCV (Tajikistan), and the TB Europe Coalition within the COMBAT DR-TB interregional project, funded by Unitaid.
